The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease

Research on the neuroprotective effect of pituitary adenylate cyclase-activating polypeptide (PACAP) and its use as a therapeutic agent has grown over the past 30 years. Both in vitro and in vivo experiments have shown that PACAP exerts a strong neuroprotective effect in many central and peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherait, Asma, Banks, William A., Vaudry, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459484/
https://www.ncbi.nlm.nih.gov/pubmed/37631246
http://dx.doi.org/10.3390/pharmaceutics15082032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459484/
https://www.ncbi.nlm.nih.gov/pubmed/37631246
http://dx.doi.org/10.3390/pharmaceutics15082032

Ejemplares similares